A detailed history of Vestcor Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Vestcor Inc holds 3,949 shares of CTLT stock, worth $250,682. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,949
Previous 3,949 -0.0%
Holding current value
$250,682
Previous $222,000 7.66%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$42.56 - $59.82 $1,276 - $1,794
-30 Reduced 0.75%
3,949 $223,000
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $1,512 - $2,188
-47 Reduced 1.17%
3,979 $179,000
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $1,193 - $1,355
-27 Reduced 0.67%
4,026 $183,000
Q2 2023

Aug 15, 2023

SELL
$31.86 - $67.26 $955,800 - $2.02 Million
-30,000 Reduced 88.1%
4,053 $176,000
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $1.36 Million - $2.23 Million
30,000 Added 740.19%
34,053 $2.24 Million
Q4 2022

Feb 15, 2023

BUY
$41.39 - $81.0 $1,779 - $3,483
43 Added 1.07%
4,053 $182,000
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $3,618 - $5,655
50 Added 1.26%
4,010 $290,000
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $109,261 - $142,904
1,253 Added 46.29%
3,960 $425,000
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $56,984 - $75,316
605 Added 28.78%
2,707 $300,000
Q4 2021

Feb 15, 2022

SELL
$119.57 - $139.07 $48,784 - $56,740
-408 Reduced 16.25%
2,102 $269,000
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $37,772 - $49,253
-346 Reduced 12.11%
2,510 $334,000
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $31,607 - $36,442
-315 Reduced 9.93%
2,856 $309,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $3,451 - $4,259
34 Added 1.08%
3,171 $334,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $22,929 - $28,131
-267 Reduced 7.84%
3,137 $326,000
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $247,606 - $314,870
3,404 New
3,404 $292,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.